Where industry leaders will share insights on implementing and scaling AI across the pharmaceutical value chain.
AI in pharma and healthcare has moved beyond the hype, entering a critical phase of adoption and scale. The focus is no longer on whether AI works, it’s about embedding it at scale to transform every stage of healthcare operations. From accelerating drug discovery to streamlining clinical trials and personalizing patient engagement, AI holds the key to reshaping the healthcare industry.
The 2025 AI for Pharma and Healthcare Conference is designed to tackle these challenges head-on, providing actionable insights, real use cases and practical strategies for scaling AI effectively.
Join Us for Innovative Discussions on
Navigating AI Adoption: Gain the insights and strategies needed to navigate the complexities of scaling AI integration, from ethical considerations and AI literacy to regulatory constraints
Drug Discovery at Scale: From target identification to precision screening, AI has proven its value. The next step is scaling these breakthroughs to reduce timelines and boost success rates across the drug development pipeline
Clinical Trials 2.0: AI is streamlining patient recruitment, trial management, and real-world evidence collection. The conference will explore how to make AI-powered trials the norm, optimizing efficiency and compliance
Commercial Strategies: AI-driven tools are revolutionising patient engagement and marketing. Scaling these solutions enables pharma companies to deliver targeted therapies and create long-term value at an unprecedented scale
Why is now the time to join the discussion?
AI for Pharma & Healthcare is brought to you at a critical time for innovation, as the below demonstrates the rate of innovation, size of current market and critical importance to stay at the cusp of latest technologies and innovations.
95% Of pharmaceutical companies reported that they are investing in AI capabilities.
70% That's how much AI could reduce the cost of discovering new drugs.
$187.95Bn The estimated growth of the AI in healthcare market by 2030.
88% Of pharmaceutical companies see AI as crucial for achieving operational efficiencies.
Very valuable to get an insight what other companies are planning, what challenges they have and discuss possible solutions
Great value event, enjoyed networking and the latest thinking from like minded professionals
Great experience. Benchmarking and networking opportunities was great! Especially liked the What IF scenarios and discussions around that
2025 Speaker Faculty
Galina Gray, SVP Digital Transformation, Bayer
Zhaoling Meng, AVP, Global Head Clinical Modeling & Evidence Integration, Digital and Data Sciences, Sanofi
Shameer Khader, Executive Director - Precision Medicine and Computational Biology, Sanofi
Sean Buckley, Chief Information Officer, Immunocore
Rajvir Madan, Chief Digital and Information Technology Officer, Arcutis Biotherapeutics
Thirupathi Pattipaka, Global Director, DataScience & AI, Novartis
Sam Khalil, Vice President, Head of FounData AI Platform, Novo Nordisk
Christos Varsakelis, Associate Director of AI & ML, Janssen
Dr Zara Ghazoui, Director, Digital Innovation, Oncology Medical, AstraZeneca
Nishtha Jain, Head of Innovation and Digital Technology, Takeda
Émilie Louvet, AstraZeneca, Director Regulatory Data Products, Digital Regulatory, Regulatory Affairs
Julia Chernova, Digital Health Expert, Bayer Pharmaceuticals
Cedric Verschueren, Head of Ethics & Business Integrity, Sanofi
Kerry Sheehan, AI Policy, Strategy and Regulation Specialist, UK Govt
Ghaith Sankari, Head of Global Digital Health & Data Science, Bayer
Raul Mora, Senior Strategic Operational Intelligence Lead/Senior Development Excellence Lead, Roche
Katriona Brooksbank, Innovation Lead, R&I Innovation Lead, NHS GGC Hon. Senior Lecturer, School of Cardiovascular & Metabolic Health, University of Glasgow
Richard Dasselaar, Digital Transformation & Strategy Leader, Modern Dental Group
Debarshi Dey, Vice President, Head of Biometrics, Galapagos
Oliver Patel, Enterprise AI Governance Lead, AstraZeneca
Skye Hodson, Vice President, Advanced Analytics, Centre of Excellence, Syneous Health
Geraldine Low, Lead Product Designer, Artificial Intelligence and Machine Learning, GSK
Lorenzo De Angelis, Architect Data & AI, European Medicines Agency
Vladimir Nimec, Director Data & AI, Daiichi Sankyo
Roberta Pandolfi, Analytics Innovation Strategist, Boehringer Ingelheim
Sebastian Sbirna, Data Governance - Global Data and AI, Novo Nordisk
Muhammad Salman Saif, Senior Director - Digital Transformation, (Gen) AI Global Strategy, Argenx
Divya Olofsson, Head of Data, Analytics and AI, Oriola
Jordi Escayola, Head of Advanced Analytics, Artificial Intelligence and Data Science (Director), Sanofi Customer Healthcare – Opella
Michael Schorpp, Head of Digital Innovation & AI, Global Regulatory Affairs, Boehringer ingelheim
Juan Ignacio Pascual, Director Global Business Adoption, Johnson & Johnson Innovative Medicine
Ulrik Ulrik Tirsted Zeuthen, Data and AI Director, Novo Nordisk
Varun V, Director Data Science, Novartis
Alice Smith, Generative AI Portfolio Manager, AstraZeneca
Matthieu Duvinage, Principal Data Scientist Ai & Dtwin, GSK
Please fill in your name and email to receive the Conference Agenda of this event.
Main Conference - 23-24 September
Workshop day - 22 September
Venue
Novotel Amsterdam City Europaboulevard 10, 1083 AD Amsterdam Netherlands
+31 20 721 9179
Group Rate: Please see below the link to book bedrooms, we have a discounted block for our conference attendees at a rate of €209.00.
